{"Symbol": "ALVO", "AssetType": "Common Stock", "Name": "Alvotech", "Description": "Alvotech Holdings SA, develops and manufactures biosimilars for global markets. The company is headquartered in Iceland.", "CIK": "1898416", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "DRUG MANUFACTURERS - SPECIALTY & GENERIC", "Address": "9, RUE DE BITBOURG, LUXEMBOURG, LUXEMBOURG, 1273", "OfficialSite": "https://www.alvotech.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-09-30", "MarketCapitalization": "1445829000", "EBITDA": "63248000", "PERatio": "20.17", "PEGRatio": "None", "BookValue": "-0.589", "DividendPerShare": "None", "DividendYield": "None", "EPS": "0.23", "RevenuePerShareTTM": "1.981", "ProfitMargin": "0.121", "OperatingMarginTTM": "-0.0262", "ReturnOnAssetsTTM": "0.0198", "ReturnOnEquityTTM": "0", "RevenueTTM": "573350000", "GrossProfitTTM": "318742000", "DilutedEPSTTM": "0.23", "QuarterlyEarningsGrowthYOY": "-0.584", "QuarterlyRevenueGrowthYOY": "0.106", "AnalystTargetPrice": "22.17", "AnalystRatingStrongBuy": "1", "AnalystRatingBuy": "3", "AnalystRatingHold": "1", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "20.17", "ForwardPE": "9.61", "PriceToSalesRatioTTM": "2.522", "PriceToBookRatio": "-", "EVToRevenue": "4.703", "EVToEBITDA": "23.86", "Beta": "0.117", "52WeekHigh": "12.89", "52WeekLow": "4.32", "50DayMovingAverage": "5.08", "200DayMovingAverage": "7.56", "SharesOutstanding": "311601000", "SharesFloat": "106071000", "PercentInsiders": "61.766", "PercentInstitutions": "6.061", "DividendDate": "None", "ExDividendDate": "None"}